In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188

被引:21
作者
Espuelas, S
Legrand, P
Loiseau, PM
Bories, C
Barratt, C
Irache, JM [1 ]
机构
[1] Univ Navarra, Fac Farm, Dept Farm & Tecnol Farmaceut, E-31080 Pamplona, Spain
[2] Univ Paris Sud, Fac Pharm, UMR 86, F-92296 Chatenay Malabry, France
[3] Univ Paris Sud, Fac Pharm, UPRES EA 398, F-92296 Chatenay Malabry, France
关键词
D O I
10.1128/AAC.44.8.2190-2192.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A micellar formulation of amphotericin B (AmB) solubilized with poloxamer 188 was evaluated against an AmB Leishmania donovani-resistant line. A concave isobologram showed a synergistic effect of this association against promastigotes. This result was confirmed with amastigotes since the 50% effective concentration of the new formulation was 100 times less than that of the control AmB formulation.
引用
收藏
页码:2190 / 2192
页数:3
相关论文
共 24 条
[21]   ENHANCED ACTION OF AMPHOTERICIN-B ON LEISHMANIA-MEXICANA RESULTING FROM HEAT TRANSFORMATION [J].
RAMOS, H ;
MILHAUD, J ;
COHEN, BE ;
BOLARD, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) :1584-1589
[22]   Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony [J].
Sundar, S ;
Agrawal, NK ;
Sinha, PR ;
Horwith, GS ;
Murray, HW .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (02) :133-137
[23]  
*US PHARM CONV INC, 2000, USP 24NF 19 POL, P2492
[24]   A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis [J].
Yardley, V ;
Croft, SL .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (04) :243-248